Vaishali Pharma Ltd began its journey with a deep commitment to delivering safe, effective, and affordable medicines. Over the years, this vision has grown into a global mission, touching lives across countries and communities.
From life-saving pharmaceuticals and APIs to nutraceuticals and surgical products, Vaishali Pharma has built a diverse portfolio that meets the ever-evolving needs of healthcare. Every product reflects the company’s dedication to quality, backed by WHO-GMP and ISO certifications.
But beyond products, Vaishali Pharma stands for trust. Hospitals, research institutions, and healthcare providers rely on its expertise to ensure patient well-being. With each step forward, the company strengthens its promise—bringing innovation, integrity, and care to the world of medicine.
Vaishali Pharma Share Price Target 2025 to 2030
| Year | Expected Share Price Range (₹) |
|---|---|
| 2025 | ₹13.25 – ₹18.75 |
| 2026 | ₹18.10 – ₹20.85 |
| 2027 | ₹20.50 – ₹24.95 |
| 2028 | ₹25.30 – ₹30.65 |
| 2029 | ₹30.75 – ₹35.90 |
| 2030 | ₹35.40 – ₹42.80 |
Vaishali Pharma Share Price Target and Future Growth
Vaishali Pharma is growing steadily, and its stock has strong potential. Based on market trends and performance, here are the expected price targets:
- Vaishali Pharma Share Price Target 2025 – ₹13.25 to ₹18.75. The stock may see gradual growth depending on revenue, new projects, and overall industry trends.
- Vaishali Pharma Share Price Target 2026 – ₹18.10 to ₹20.85. With improving financials and higher demand for pharmaceutical products, the stock could see moderate growth.
- Vaishali Pharma Share Price Target 2027 – ₹20.50 to ₹24.95. Expansion into new markets and strong earnings could drive the stock further.
- Vaishali Pharma Share Price Target 2028 – ₹25.30 to ₹30.65. As the company strengthens its market position, its stock may reflect steady and stable growth.
- Vaishali Pharma Share Price Target 2029 – ₹30.75 to ₹35.90. Increased global presence and strategic partnerships could support long-term growth.
- Vaishali Pharma Share Price Target 2030 – ₹35.40 to ₹42.80. If the company continues to perform well, the stock may reach higher levels with consistent profitability.
Vaishali Pharma Ltd – Fundamental
| Metric | Value |
|---|---|
| Market Cap | ₹154 Cr |
| P/E Ratio (TTM) | 358.00 |
| P/B Ratio | 2.35 |
| Industry P/E | 54.08 |
| Debt to Equity | 0.19 |
| ROE (Return on Equity) | 1.62% |
| EPS (TTM) | 0.04 |
| Dividend Yield | 0.00% |
| Book Value | 6.10 |
| Face Value | 2 |
Vaishali Pharma Ltd – Income Statement (Dec ‘2024)
| Particulars | Dec ‘2024 |
|---|---|
| Revenue | ₹28.98 Cr |
| Expenses | ₹27.05 Cr |
| EBITDA | ₹2.43 Cr |
| EBIT | ₹2.31 Cr |
| Profit Before Tax | ₹1.92 Cr |
| Net Profit | ₹1.44 Cr |
Read More: Zomato Share Price Target
Financial Ratios (Dec ‘2024)
| Metric | Dec ‘2024 |
|---|---|
| Operating Profit Margin | 8.71% |
| Net Profit Margin | 5.16% |
| Earnings Per Share (EPS) | 0.98 |
| Dividends Per Share | 0.00 |
Vaishali Pharma Ltd – Balance Sheet (2024)
| Particulars | 2024 |
|---|---|
| Total Assets | ₹79.96 Cr |
| Current Assets | ₹74.52 Cr |
| Non-Current Assets | ₹5.44 Cr |
| Total Liabilities | ₹37.12 Cr |
| Current Liabilities | ₹33.08 Cr |
| Non-Current Liabilities | ₹4.03 Cr |
| Total Equity | ₹42.84 Cr |
| Common Stock | ₹10.72 Cr |
| Preferred Stock | ₹0.00 Cr |
| Other Equity Total | ₹32.12 Cr |
| Total Common Shares Outstanding | 1.07 |
| Debt to Equity Ratio | 0.34 |
| Book Value | ₹39.97 Cr |
Vaishali Pharma Ltd – Shareholding Pattern (Dec 2024)
| Category | Shareholding (%) |
|---|---|
| Retail & Others | 73.68% |
| Promoters | 26.32% |
Conclusion
Vaishali Pharma is growing in the pharmaceutical industry, and its stock looks promising for the future. The Vaishali Pharma Share Price Target shows that the price may increase over time if the company continues to do well. However, stock prices can go up and down due to market trends, economic conditions, and company performance. It is always a good idea to do research and understand the risks before investing.
FAQ
What does Vaishali Pharma do?
Vaishali Pharma is a pharmaceutical company that makes and sells medicines, APIs, nutraceuticals, and surgical products in India and other countries.
Can Vaishali Pharma be a multibagger stock?
If Vaishali Pharma continues to grow and expand, it may have the potential, but nothing is guaranteed in the stock market.
Does Vaishali Pharma have international business?
YES.
How does Vaishali Pharma compare to other pharma stocks?
Vaishali Pharma is a smaller player compared to big pharmaceutical companies, but it is growing steadily. Investors should compare financials, revenue, and future plans before investing.
